News | SummitMD
News
News | SummitMD
2nd SGLT-2 Inhibitor Scores in HF as Empagliflozin Reduces Hospitalization, CV Death in HFrEF
EMPEROR-Reduced: diabetes drug empagliflozin shows significant CV, renal benefits in HFrEF regardless of diabetes status
News | ACT Program
1st Virtual ACT Program Held
The "A"san Medical Center Interventional "C"ardiology "T"raining Program (hereinafter referred to as ACT Program) was successfully held online for the first time for two days on June 19th (Fri) and 20th (Sat) by attracting approximately 600 participants.
News | TCTAP & AP VALVES 2020 Virtual
Choice of Stent Platforms in HBR Patients - Insights from the ONYX-ONE Trial
August 8th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL
News | TCTAP & AP VALVES 2020 Virtual
A New Algorithm from Japanese CTO-PCI Expert Registry
August 8th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL
ISSN: 3058-6437 | °£Ç๰µî·Ï¹øÈ£: ¼ÛÆÄ,¸¶00061 | µî·ÏÀÏÀÚ: 2024³â 10¿ù 10ÀÏ | ¹ßÇàÀÎ/ÆíÁýÀÎ: ¹Ú½ÂÁ¤